Rachel L. Sargent, MD

faculty photo
Assistant Professor of Clinical Pathology and Laboratory Medicine
Department: Pathology and Laboratory Medicine

Contact information
The Hospital of the University of Pennsylvania
3400 Spruce Street
7.103 Founders Pavilion
Philadelphia, PA 19104
Office: 215-662-7798
Fax: 215-662-7529
Education:
BS (Biology, Magna Cum Laude)
Ursinus College, 1994.
MD
University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, 2001.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

McMahon CM, Canaani J, Rea B, Sargent RL, Morrissette JJD, Lieberman DB, Watt C, Schwartz GW, Faryabi RB, Ferng TT, Shah NP, Smith CC, Carroll M, Perl AE.: Mechanisms of Acquired Resistance to Gilteritinib Therapy in Relapsed and Refractory FLT3-Mutated Acute Myeloid Leukemia. American Society of Hematology, 59th Annual Meeting & Exposition, Atlanta, GA Dec 2017.

Cherng HJJ, Sargent RL, Nasta SD, Svoboda J, Schuster SJ, Mato AR, April Schrank-Hacker A, Morrissette JJD, Landsburg DJ: Interim PET-CT Result Is Not Predictive of Survival in Patients with MYC-Rearranged Non-Burkitt Aggressive B Cell Lymphoma. American Society of Hematology, 59th Annual Meeting & Exposition, Atlanta, GA Dec 2017.

Svoboda J, Landsburg DJ, Nasta SD, Barta SK, Khan N, Fung HC, Tan CR, Filicko-O'Hara J, Gaballa S, Strelec LE, Nagle SJ, Bair SM, Mitnick S, Waite TS, Sargent RL, Bogusz AM, Sahin Z, Mato AR, Schuster SJ.: Brentuximab Vedotin with R-CHP Chemotherapy As Frontline Treatment for Patients with CD30 Positive Primary Mediastinal Large B-Cell, Diffuse Large B-Cell, and Grey Zone Lymphomas: Results of a Phase I/II Multisite Trial. American Society of Hematology, 59th Annual Meeting & Exposition, Atlanta, GA Dec 2017.

Hao S, Lin P, Medeiros LJ, Fang L, Carballo-Zarate AA, Konoplev SN, Sargent RL, Weber DM, Thomas SK, Manasanch EE, Orlowski RZ, Lu X: Clinical implications of cytogenetic heterogeneity in multiple myeloma patients with TP53 deletion. Mod Path 30(10): 1378-1386, October 2017 Notes: Published under first name and middle initial.

Wertheim G, Pillai V, Sargent R, Paessler M, Lewen M, Li J, Master S, Carroll M, Luskin M.: EVI1 Immunohistochemistry Identifies AML Subtypes with Distinct Genetics and Prognosis United States & Canadian Academy of Pathology, 106th Annual Meeting; Modern Pathology 30(Supplement 2): 385A, February 2017.

Monaghan S, Felgar R, Kelly M, Ali A, Anastasi J, Bellara A, Rinder H, Sargent R, Wagner J, Swerdlow S, Johnson R: Does taking the Fellowship In-Service Hematopathology Exam and performance relate to success on the American Board of Pathology Hematology Examination? Am J Clin Pathol 146(1): 107-12, Jul 2016 Notes: Published under last and first name only.

Brannock K and Sargent RL: Society of Hematopathology Case of the Quarter: Autoimmune Myelofibrosis. Society of Hematopathology/American Society of Clinical Pathology Case of the Quarter website. http://www.sh-eahp.org June 2016 Notes: Published under last and first name and middle initial.

Canaani J, Rea B, Sargent R, Morrissette J, Lieberman D, Watt C, Carroll M, Perl A: Differentiation Response to Gilteritinib (ASP2216) in Relapsed/Refractory FLT3 Mutated Acute Myeloid Leukemia Patients is Associated with Co-mutations in NPM1. 21st Congress of the European Hematology Association Annual Meeting, Copenhagen, Denmark June 2016 Notes: Published under last and first name only.

Brannock KR, Sargent R.: Autoimmune myelofibrosis: A case report and review of the literature. 2016 Atlantic Regional Hematopathology Meeting, Philadelphia, PA. May 2016.

Reilly CR, Sargent RL, Sarkar M: Secondary autoimmune myelofibrosis associated with rheumatoid arthritis: a rare but steroid-responsive cause of bone marrow failure. Annals of Hematology and Oncology 3(1): 1071-1073, March 2016 Notes: Published under last and first name and middle initial.

back to top
Last updated: 11/29/2017
The Trustees of the University of Pennsylvania